Abstract
Abstract
Purpose
Diagnosis of (European) Lyme neuroborreliosis has been based on clinical presentation, cerebrospinal fluid (CSF) pleocytosis and demonstration of intrathecal borrelial antibody synthesis (ITBAS) to document Borrelia burgdorferi s. l. infection. It is not known if other criteria to document Borrelia infection may contribute to the diagnosis.
Methods
We compared the sensitivity of three individual criteria (ITBAS, CSF Borrelia culture, and the presence of erythema migrans [EM]) to confirm the diagnosis of early Lyme neuroborreliosis in 280 patients ≥ 15 years of age evaluated at a Lyme borreliosis outpatient clinic in Slovenia. The patients had either radicular pain of new onset or involvement of a cranial nerve but without radicular pain, each in conjunction with CSF pleocytosis. Evaluation was of patients who had each of the three confirmatory criteria assessed, and for whom at least one criterion was positive.
Results
Analysis of 280 patients, 120 women and 160 men, median age 57 (range 15–84) years, revealed that ITBAS was the most frequently observed positive criterion (85.4%), followed by EM (52.9%), and by a positive CSF Borrelia culture (9.6%). Of the 280 patients, 154 (55%) met only one criterion (43.2% ITBAS only, 10.7% EM only, and 1.1% positive CSF culture only), whereas 42.1% met two criteria. Only 2.9% of patients were positive by all three criteria.
Conclusion
Although ITBAS was the most frequent criterion for confirmation for Borrelia infection, the presence of EM alone confirmed an additional 10.7% of patients and a positive CSF Borrelia culture alone added another 1.1%.
Funder
University Medical Centre Ljubljana, Slovenia
US National Institute of Allergy and Infectious Diseases
US National Institute of Arthritis and Musculosceletal and Skin Diseases
Slovenian Research and Innovation Agency
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Stanek G, Strle F. Lyme borreliosis-from tick bite to diagnosis and treatment. FEMS Microbiol Rev. 2018. https://doi.org/10.1093/femsre/fux047.
2. Strle F, Stanek G. Clinical manifestations and diagnosis of lyme borreliosis. Curr Probl Dermatol. 2009. https://doi.org/10.1159/000213070.
3. Ruzić-Sabljić E, Maraspin V, Cimperman J, Lotric-Furlan S, Strle F. Evaluation of immunofluorescence test (IFT) and immuno (western) blot (WB) test in patients with erythema migrans. Wien Klin Wochenschr. 2002;114(13–14):586–90. PMID: 12422606.
4. Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001. https://doi.org/10.1016/S0022-510X(00)00501-3.
5. Ogrinc K, Lusa L, Lotrič-Furlan S, et al. Course and outcome of early European Lyme neuroborreliosis (Bannwarth Syndrome): clinical and laboratory findings. Clin Infect Dis. 2016. https://doi.org/10.1093/cid/ciw299.